| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421949A1 Novel nucleic acids and polypeptides |
| 03/21/2002 | CA2421836A1 Pest control system |
| 03/21/2002 | CA2421751A1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | CA2421582A1 Combinatorial fluorescence energy transfer tags and uses thereof |
| 03/21/2002 | CA2421303A1 Novel compounds |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420932A1 Novel mammalian nuclear receptor l66 and methods of use |
| 03/21/2002 | CA2420892A1 Human coagulation factor vii variants |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/21/2002 | CA2419154A1 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample |
| 03/21/2002 | CA2418724A1 Target activated nucleic acid biosensor and methods of using same |
| 03/21/2002 | CA2391626A1 Combinatorial screening of mixed populations of organisms |
| 03/21/2002 | CA2391407A1 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/20/2002 | EP1188835A1 A vector for the expression of two foreign genes |
| 03/20/2002 | EP1188834A1 Recombinant MVA expressing the HER-2/neu gene |
| 03/20/2002 | EP1188833A1 A method for producing plants which are resistant to closteroviruses |
| 03/20/2002 | EP1188832A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/20/2002 | EP1188831A2 Target of RNAIII activating protein (TRAP) |
| 03/20/2002 | EP1188830A1 Novel hemopoietin receptor protein nr10 |
| 03/20/2002 | EP1188829A2 Antibiotic hypersusceptibility mutations in bacteria |
| 03/20/2002 | EP1188827A1 Processes for the fusion of dendritic cells with tumor cells and media for such processes |
| 03/20/2002 | EP1188826A2 5-substituted hydantoin racemase, DNA coding for the same, and process for producing optically active amino acids |
| 03/20/2002 | EP1188823A1 Transformed microorganism and process for producing d-aminoacylase |
| 03/20/2002 | EP1188822A1 L-amino acid-producing bacteria and process for producing l-amino acid |
| 03/20/2002 | EP1188771A1 Libraries of human heavy chain variable fragments in a functional format |
| 03/20/2002 | EP1188448A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 03/20/2002 | EP1188446A1 Proteinaceous vectors for molecule delivery to CD11b expressing cells |
| 03/20/2002 | EP1188056A1 Use of gabapentin in assays to identify gabab receptor modulators |
| 03/20/2002 | EP1188049A1 Capillary electrophoresis method for screening for affinity ligands using a detectable competitive ligand |
| 03/20/2002 | EP1187939A2 Detection of hiv-1 by nucleic acid amplification |
| 03/20/2002 | EP1187938A1 Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans |
| 03/20/2002 | EP1187937A1 Solid phase methods for amplifying multiple nucleic acids |
| 03/20/2002 | EP1187936A2 Automatable rapid test for detecting cancers, on the basis of telomerase(htc) mrna and specific primers and probes |
| 03/20/2002 | EP1187935A2 Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187930A1 A global regulator used to enhance the synthesis of aromatic substances |
| 03/20/2002 | EP1187929A2 Novel liposomal vector complexes and their use in gene therapy |
| 03/20/2002 | EP1187928A2 Virus like particles, preparation and use in screening and functional genomics |
| 03/20/2002 | EP1187927A2 Hcv/bvdv chimeric genomes and uses thereof |
| 03/20/2002 | EP1187926A1 Promoters from atlantic salmon |
| 03/20/2002 | EP1187925A1 Pectate lyase fusion for expression and secretion of polypeptides |
| 03/20/2002 | EP1187924A1 Substrate trapping protein tyrosine phosphatases |
| 03/20/2002 | EP1187923A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 03/20/2002 | EP1187922A2 Pesticidal proteins |
| 03/20/2002 | EP1187921A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development |
| 03/20/2002 | EP1187920A2 Recombinant prion-like genes and proteins and materials and methods comprising same |
| 03/20/2002 | EP1187919A2 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 03/20/2002 | EP1187918A1 Tek antagonists |
| 03/20/2002 | EP1187917A1 Cd44 splice variant associated with rheumatoid arthritis |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187914A1 A structured peptide scaffold for displaying turn libraries on phages |
| 03/20/2002 | EP1187913A1 Screening method for peptides |
| 03/20/2002 | EP1187912A1 In vivo insect model system for type-2 diabetes |
| 03/20/2002 | EP1187911A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 03/20/2002 | EP1187910A1 Methods for enhancing plant defense |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 03/20/2002 | EP1187851A1 Novel integrin alpha subunit and uses thereof |
| 03/20/2002 | EP1187850A1 Antimicrobial theta defensins and methods of using same |
| 03/20/2002 | EP1187849A1 Meth1 and meth2 polynucleotides and polypeptides |
| 03/20/2002 | EP1187845A2 Tumor suppressor molecules and methods of use |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187841A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
| 03/20/2002 | EP1187840A1 Methods of dna purification and purified dna |
| 03/20/2002 | EP1187807A1 Bipolar lipids and their use for the delivery of bioactive substances |
| 03/20/2002 | EP1187806A2 Spermine:peptide-based surfactant compounds |
| 03/20/2002 | EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/20/2002 | EP1187627A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 03/20/2002 | EP1187626A1 Methods for producing 5'-nucleic acid-protein conjugates |
| 03/20/2002 | EP1187620A1 Antisense modulation of b7 protein expression |
| 03/20/2002 | EP1187591A2 Ibd-associated microbial antigens and methods of using same |
| 03/20/2002 | EP1019842B1 Control of nucleic acid amplification procedures including the polymerase chain reaction (pcr) |
| 03/20/2002 | EP0986568B1 Novel class of nucleic acid cationic transfecting agents |
| 03/20/2002 | EP0963443A4 Releasable nonvolatile mass-label molecules |
| 03/20/2002 | EP0918786A4 Nuclease protection assays |
| 03/20/2002 | EP0895546A4 Methods of isolating biological target materials using silica magnetic particles |
| 03/20/2002 | EP0871548B1 Reversibly, non-covalent bound surface coating |
| 03/20/2002 | EP0861332B1 A method of sequencing |
| 03/20/2002 | EP0801689A4 Method of screening for genetic predisposition to anticholinesterase therapy |
| 03/20/2002 | EP0725682B1 Microfabricated, flowthrough porous apparatus |
| 03/20/2002 | EP0647710B1 Novel protease |
| 03/20/2002 | EP0628077B1 Humanised antibodies directed against a33 antigen |
| 03/20/2002 | EP0610475B1 Nerve-derived transglutaminase enzyme useful for inducing nerve regeneration |
| 03/20/2002 | EP0593501B1 Biocidal proteins |
| 03/20/2002 | EP0591385B1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 03/20/2002 | EP0589961B1 Assay systems for neurotrophin activity |
| 03/20/2002 | EP0418316B1 Platelet-specific chimeric immunoglobulin |
| 03/20/2002 | CN1341151A Herbicide target gene and methods |
| 03/20/2002 | CN1341150A 疟疾疫苗 Malaria Vaccine |
| 03/20/2002 | CN1341148A Nucleic acid molecules encoding alternansucrase |
| 03/20/2002 | CN1341146A Fungal cells with inactivated DNA mismatch repair system |
| 03/20/2002 | CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof |
| 03/20/2002 | CN1341123A Novel G protein-coupled receptor protein and DNA thereof |
| 03/20/2002 | CN1341121A Expression and export of anti-obesity proteins as Fc fusion proteins |
| 03/20/2002 | CN1341120A 骨刺激因子 Bone stimulator |
| 03/20/2002 | CN1341118A Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart disease |